D.E. Shaw & Co’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

D.E. Shaw & Co’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14,335	Closed	-$8K	–	4470
2019 Q4	$8K	Buy	+14,335	New	+$34.8K	﹤0.01%	3924
2019 Q3	–	Sell	-53,672	Closed	-$357K	–	4130
2019 Q2	$357K	Buy	+53,672	New	+$204K	﹤0.01%	3238

D.E. Shaw & Co's MLNT Position: Q1 2020 in Review

D.E. Shaw & Co sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 14,335 shares — an estimated $8K sold.

D.E. Shaw & Co first reported a position in MLNT in Q2 2019 and held it in 2 quarters. The position peaked at $357K in Q2 2019. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

D.E. Shaw & Co reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
D.E. Shaw & Co sold 14,335 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $8K.
D.E. Shaw & Co first reported a position in Melinta Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
D.E. Shaw & Co's Melinta Therapeutics, Inc. Common Stock position peaked at $357K in Q2 2019.
2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.